FLUARIX QUADRIVALENT Rx

Generic Name & Formulations:

Quadrivalent inactivated “split virus” influenza vaccine (types A and B); contains a total of 60mcg hemagglutinin per 0.5mL dose; formulation changes annually; susp for IM inj; may contain trace amounts of hydrocortisone, gentamicin, others; preservative-free.

Company:

GlaxoSmithKline

Vaccines

Vaccines:

Indications for: FLUARIX QUADRIVALENT

Influenza immunization.

Adults and Children:

<6mos: not established. Each dose is 0.5mL by IM inj once in the anterolateral thigh (6–11mos) or the deltoid (≥12mos). 6mos–8yrs (previously unvaccinated): 2 doses, give at least 4 weeks apart; (vaccinated in a previous season): 1 or 2 doses (depending on vaccination history as per annual ACIP recommendation); if 2 doses, give at least 4 weeks apart. ≥9yrs: 1 dose.

FLUARIX QUADRIVALENT Contraindications:

Allergy to egg protein or following a previous flu vaccine administration.

FLUARIX QUADRIVALENT Warnings/Precautions:

Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Bleeding disorders. Immunosuppressed. Risk of sycope with injectable vaccines. Have epinephrine inj (1:1000) available. Pregnancy. Nursing mothers.

FLUARIX QUADRIVALENT Classification:

Influenza vaccine.

FLUARIX QUADRIVALENT Interactions:

Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may result in suboptimal response.

Adverse Reactions:

Local reactions (eg, redness, swelling, pain), muscle aches, fatigue, headache, arthralgias, GI symptoms, shivering, fever; children: irritability, loss of appetite, drowsiness.

Generic Drug Availability:

NO

How Supplied:

Single-dose prefilled Tip-Lok syringes (0.5mL)—10